XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.21.1

Earnings Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
Earnings Per Share [Abstract] |
Schedule of earnings per share, basic and diluted | A computation of earnings per share from continuing operations and weighted average shares of the Company's common stock outstanding for the three months ended March 31, 2021 and 2020 is as follows:
| Three Months Ended March 31, |  |
(dollars in millions, except per share amounts) | 2021 |  | 2020 |  |  |  |
Net income from continuing operations attributable to common stockholders | $ | 82.3 |  |  | $ | 8.4 |  |  |  |  |
Basic weighted average common shares outstanding | 247.2 |  |  | 250.3 |  |  |  |  |
Denominator adjustments for diluted EPS: |  |  |  |  |  |  |
Number of shares issuable upon conversion of Series A Preferred Stock | — |  |  | 1.2 |  |  |  |  |
Number of stock options and RSUs | 1.4 |  |  | 0.5 |  |  |  |  |
Denominator adjustments for diluted EPS | 1.4 |  |  | 1.7 |  |  |  |  |
Diluted weighted average common shares outstanding | 248.6 |  |  | 252.0 |  |  |  |  |
Earnings per share from continuing operations attributable to common stockholders: |  |  |  |  |  |  |
Basic | $ | 0.33 |  |  | $ | 0.03 |  |  |  |  |
Diluted | $ | 0.33 |  |  | $ | 0.03 |  |  |  |  |
Schedule of antidilutive securities excluded from computation of earnings per share | For the three months ended March 31, 2021 and 2020, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet met for awards contingent upon such measures:
| Three Months Ended March 31, |  |
(shares in millions) | 2021 |  | 2020 |  |  |  |
Shares issuable upon vesting of RSUs and exercise of stock options | 3.0 |  |  | 4.9 |  |  |  |  |
Total | 3.0 |  |  | 4.9 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration